FindTrial
Sign In

A Study on Patient-Reported Outcomes for Acute Toxicity in Breast Cancer Patients Undergoing Radiation Therapy and Its Impact on Quality of Life

A Prospective Study On Patient Reported Outcomes For Acute Toxicity In Breast Cancer Patients Receiving Radiation Therapy And Its Impact On Quality Of Life - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/076905
Enrollment
40
Registered
2024-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50-C50- Malignant neoplasms of breast

Interventions

Control Intervention1: NIL: NIL

Sponsors

Dr Lucky Kumawat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 years Female patients Biopsy proven invasive breast cancer Post operative breast cancer patients having standard indication of radiation therapy Non metastatic

Exclusion criteria

Exclusion criteria: Recurrence of disease in ipsilateral or contralateral side Patients who have previously received radiation therapy to chest

Design outcomes

Primary

MeasureTime frame
Base don the findings there might be recommendations for adjusting radiation therapy parameters to improve the balance between treatment efficacy and quality of life preservationTimepoint: At start of the treatment , at the completion of treatment, 3 months after completion of treatment—

Secondary

MeasureTime frame
The results will be reviewed via EORTC QLQ-C30, BR23 questionnaire at start of the treatment , at the completion of treatment, 3 months after completion of treatmentTimepoint: At start of the treatment , at the completion of treatment, 3 months after completion of treatment—

Countries

India

Contacts

Public ContactDr Rashi Agrawal
drrashi.ag@gmail.com9891483550

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026